Research Solutions, Inc.

As of October 17, 2025, Research Solutions, Inc. is considered overvalued with a valuation grade of expensive, indicated by high ratios such as a Price to Book Value of 8.01 and an EV to EBITDA of 25.94, compared to peers like PaySign, Inc. and FONAR Corp. which have significantly lower ratios.

As of October 17, 2025, Research Solutions, Inc. is considered overvalued with a Price to Book Value of 8.01 and significantly higher EV to EBITDA ratio compared to peers, alongside a year-to-date stock decline of 24.34%, contrasting with the S&P 500's gain of 13.30%.

As of September 9, 2025, Research Solutions, Inc. shows a mildly bullish technical trend with positive weekly indicators, despite mixed signals from monthly metrics and a year-to-date underperformance compared to the S&P 500.

As of November 9, 2023, Research Solutions, Inc. has shifted from a fair to a risky valuation grade, indicating it may be overvalued despite recent short-term gains, with significant disparities in valuation metrics compared to FONAR Corp. and mixed return performance year-to-date.

As of November 9, 2023, Research Solutions, Inc. is considered risky and overvalued due to its high Price to Book Value of 8.01, an EV to EBITDA ratio of 25.94, a negative ROE of -10.03%, and a year-to-date stock performance of -34.22%, contrasting sharply with more attractive peers like FONAR Corp. and the S&P 500.

As of May 1, 2025, the trend is mildly bearish, influenced by daily moving averages indicating bearish momentum, while weekly indicators show some short-term bullish strength, resulting in mixed signals overall.

As of March 2022, the management team of Research Solutions, Inc. includes Mr. John Regazzi (Independent Chairman), Mr. Peter Derycz (President and CEO), and Independent Directors Mr. Chad Cooper, Gen. (Retd.) Merrill McPeak, and Mr. Roy Olivier. They oversee the company's strategic direction and governance.

Research Solutions, Inc. is a holding company that offers a cloud-based SaaS research intelligence platform and manages the sale of scientific, technical, and medical content. It has a market cap of approximately $89.75 million and reported net sales of $13 million with no net profit as of March 2025.

As of Jun 18, Research Solutions, Inc. has a market capitalization of 89.75 million, with net sales of 48.74 million and a net profit of -3.91 million over the last four quarters. Shareholder's funds are 11.69 million, and total assets are 41.86 million as of June 2024.